These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
845 related articles for article (PubMed ID: 23988337)
1. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT). van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR; Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337 [TBL] [Abstract][Full Text] [Related]
2. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial. van der Marck MA; Bloem BR; Borm GF; Overeem S; Munneke M; Guttman M Mov Disord; 2013 May; 28(5):605-11. PubMed ID: 23165981 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial. Munneke M; Nijkrake MJ; Keus SH; Kwakkel G; Berendse HW; Roos RA; Borm GF; Adang EM; Overeem S; Bloem BR; Lancet Neurol; 2010 Jan; 9(1):46-54. PubMed ID: 19959398 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191 [TBL] [Abstract][Full Text] [Related]
7. Treatment effect modifiers for the patient education programme for Parkinson's disease. A'Campo LE; Wekking EM; Spliethoff-Kamminga NG; Stijnen T; Roos RA Int J Clin Pract; 2012 Jan; 66(1):77-83. PubMed ID: 22171907 [TBL] [Abstract][Full Text] [Related]
8. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823 [TBL] [Abstract][Full Text] [Related]
9. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial. Sturkenboom IH; Graff MJ; Hendriks JC; Veenhuizen Y; Munneke M; Bloem BR; Nijhuis-van der Sanden MW; Lancet Neurol; 2014 Jun; 13(6):557-66. PubMed ID: 24726066 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial. van der Kolk NM; de Vries NM; Kessels RPC; Joosten H; Zwinderman AH; Post B; Bloem BR Lancet Neurol; 2019 Nov; 18(11):998-1008. PubMed ID: 31521532 [TBL] [Abstract][Full Text] [Related]
12. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease. Santos-García D; de la Fuente-Fernández R J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935 [TBL] [Abstract][Full Text] [Related]
13. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A; Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734 [TBL] [Abstract][Full Text] [Related]
14. The clinically important difference on the unified Parkinson's disease rating scale. Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131 [TBL] [Abstract][Full Text] [Related]
15. TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial. Olanow CW; Schapira AH; LeWitt PA; Kieburtz K; Sauer D; Olivieri G; Pohlmann H; Hubble J Lancet Neurol; 2006 Dec; 5(12):1013-20. PubMed ID: 17110281 [TBL] [Abstract][Full Text] [Related]
16. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636 [TBL] [Abstract][Full Text] [Related]
17. In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial. Monticone M; Ambrosini E; Laurini A; Rocca B; Foti C Mov Disord; 2015 Jul; 30(8):1050-8. PubMed ID: 26095443 [TBL] [Abstract][Full Text] [Related]
19. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029 [TBL] [Abstract][Full Text] [Related]
20. Effect of Nintendo Wii™-based motor and cognitive training on activities of daily living in patients with Parkinson's disease: a randomised clinical trial. Pompeu JE; Mendes FA; Silva KG; Lobo AM; Oliveira Tde P; Zomignani AP; Piemonte ME Physiotherapy; 2012 Sep; 98(3):196-204. PubMed ID: 22898575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]